End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.9 CNY | -1.41% | -3.13% | -26.85% |
Business Summary
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Polypeptide Synthesis Reagent
77.6
%
| - | - | 302 | 77.6 % | - |
Universal Molecular Building Block
19.1
%
| 68 | 15.2 % | 74 | 19.1 % | +8.87% |
Protein Reagent
2.5
%
| 25 | 5.6 % | 10 | 2.5 % | -61.79% |
Other
0.9
%
| 3 | 0.7 % | 3 | 0.9 % | +6.88% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 447 | 100.0 % | 389 | 100.0 % | -13.11% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yong Zhu
CEO | Chief Executive Officer | 53 | 01/12/03 |
Xiao Yan Wang
DFI | Director of Finance/CFO | 44 | 31/01/04 |
Hao Yi Sun
CHM | Chairman | 46 | 30/06/11 |
Yu Luo
CTO | Chief Tech/Sci/R&D Officer | 46 | 09/10/20 |
Min Jie Lü
BRD | Director/Board Member | 41 | 31/08/09 |
Xue Gen Lu
BRD | Director/Board Member | 42 | 31/10/11 |
Jie Xu
BRD | Director/Board Member | 45 | 31/10/04 |
Sheng Jun Dong
SEC | Corporate Secretary | 46 | 29/02/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Qing Wang
BRD | Director/Board Member | 58 | 31/05/21 |
Yong Zhu
CEO | Chief Executive Officer | 53 | 01/12/03 |
Jie Xu
BRD | Director/Board Member | 45 | 31/10/04 |
Xue Gen Lu
BRD | Director/Board Member | 42 | 31/10/11 |
Min Jie Lü
BRD | Director/Board Member | 41 | 31/08/09 |
Qi Zhu Sun
BRD | Director/Board Member | 41 | 28/02/07 |
Yu Luo
CTO | Chief Tech/Sci/R&D Officer | 46 | 09/10/20 |
Hao Yi Sun
CHM | Chairman | 46 | 30/06/11 |
Jin Feng Li
BRD | Director/Board Member | 37 | 30/09/09 |
Xiang Guo Cai
BRD | Director/Board Member | 57 | 29/02/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,000,000 | 28,374,600 ( 26.27 %) | 200,000 ( 0.1852 %) | 26.27 % |
Company contact information
Suzhou Highfine Biotech Co., Ltd.
F-12 Standard Factory 2 Hongxi Road
215151, Suzhou
+
http://www.highfine.comSales per Business
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.85% | 653M | |
+3.66% | 104B | |
-7.78% | 62.15B | |
+75.24% | 49.04B | |
+13.54% | 37.81B | |
+0.44% | 31.1B | |
+11.92% | 20.14B | |
+10.77% | 16.52B | |
+8.20% | 13.85B | |
-4.15% | 13.11B |
- Stock Market
- Equities
- 301393 Stock
- Company Suzhou Highfine Biotech Co., Ltd.